Five years after a first MS-related attack, lower brain gray matter volume is linked to worse thinking and memory, especially as people get older.
Researchers looked at 40 people five years after their first MS-like attack and tested thinking skills like memory, attention, and problem-solving.They measured gray matter volume (the brain tissue that helps with thinking) from MRI scans and found that people with lower gray matter were more likely to have below‑normal thinking test results.The link between lower gray matter and thinking problems was stronger in older participants, meaning age made the connection clearer.Statistical analysis suggested that after about age 39, lower gray matter was more clearly related to having thinking problems on tests.These results come from one time point (five years after the first attack), so they show an association — a connection — not proof that lower gray matter causes the thinking problems.
People with MS and their caregivers should care because the study suggests brain tissue loss (lower gray matter) is tied to thinking and memory difficulties that can affect daily tasks like planning, remembering appointments, or following conversations.Older adults with MS or people approaching their 40s may want to pay extra attention to cognition, because the study found the link between brain volume and thinking problems grew stronger with age.Healthcare providers and therapists can use this information to watch for early signs of thinking changes and recommend cognitive tests or support sooner — like memory aids, pacing strategies, or brain-training exercises.Caregivers can help by keeping routines, using reminders (phone alarms, calendars), and breaking tasks into smaller steps so daily life is easier if thinking becomes harder.Researchers and clinicians might use MRI brain volume as one piece of information to decide who could benefit from early cognitive support or closer follow-up.
This study had only 40 participants and looked at one time point, so results might not apply to everyone with MS or predict how a person will change over time.The study shows a link between lower gray matter and thinking problems, but it cannot prove that brain volume loss caused the problems; other factors could also play a role.Because the finding about age centers around a rough cutoff (around 39 years) and comes from exploratory analysis, it should be seen as a helpful hint rather than a definitive rule for individual care.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds a brain‑seeking CD4 killer cell tied to MS and CMV exposure that may resist some treatme
Read More5/1/2026
Study shows after optic neuritis the ganglion cell layer (GCL) loses more tissue than the inner plex
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds specific spinal fluid proteins tied to early nerve damage in active MS, highlighting imm
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of clinical and translational neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.